Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0CPJJL)
| ADC Name |
WO2023173132A1ADC-14
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ADC-14
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.2
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
P9
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
DIBAC-suC-PEG24-P9
|
|||||